Product news from 01/20/06 News Brief
The FDA approved Merck’s Emend (aprepitant) for use with other antiemetic medicines for the prevention of nausea and vomiting associated ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.